Effects of writing about stressful experiences on symptom reduction in Patients with Asthma or rheumatoid arthritis : A randomized trial.
Context Non pharmacological treatments with little patient cost or risk are useful supplements to pharmacotherapy in the treatment of patients with chronic illness.
Research has demonstrated that writing about emotionally traumatic experiences has a surprisingly beneficial effect on symptom reports, well-being, and health care use in healthy individuals.
Objective To determine if writing about stressful life experiences affects disease status in patients with asthma or rheumatoid arthritis using standardized quantitative outcome measures.
Design Randomized controlled trial conducted between October 1996 and December 1997.
Setting Outpatient community residents drawn from private and institutional practice.
Patients Volunteer sample of 112 patients with asthma (n=61) or rheumatoid arthritis (n=51) received the intervention ; 107 completed the study, 58 in the asthma group and 49 in the rheumatoid arthritis group.
Intervention Patients were assigned to write either about the most stressful event of their lives (n=71 ; 39 asthma, 32 rheumatoid arthritis) or about emotionally neutral topics (n=41 ; 22 asthma, 19 rheumatoid arthritis) (the control intervention).
Main Outcome Measures Asthma patients were evaluated with spirometry and rheumatoid arthritis patients were clinically examined by a rheumatologist.
Assessments were conducted at baseline and at 2 weeks and 2 months and 4 months after writing and were done blind to experimental condition. (...)
Mots-clés Pascal : Asthme, Polyarthrite rhumatoïde, Protocole thérapeutique, Rédaction, Evénement existentiel, Stress, Randomisation, Amélioration, Santé, Evaluation, Homme, Appareil respiratoire pathologie, Bronchopneumopathie obstructive
Mots-clés Pascal anglais : Asthma, Rheumatoid arthritis, Therapeutic protocol, Writing, Life events, Stress, Randomization, Improvement, Health, Evaluation, Human, Respiratory disease, Obstructive pulmonary disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0234114
Code Inist : 002B26D. Création : 16/11/1999.